Literature DB >> 16930944

Attention and psychomotor speed decline in patients with temporal lobe epilepsy: a longitudinal study.

Ada Piazzini1, Katherine Turner, Rosanna Chifari, Alberto Morabito, Raffaele Canger, Maria Paola Canevini.   

Abstract

PURPOSE: To assess the possible cognitive alterations in epilepsy patients compared with controls over 5 years, and to investigate the clinical variables mainly implied in mental impairment.
METHODS: In our longitudinal single-center study, 50 patients with temporal lobe epilepsy (TLE) and 50 controls were administered the same battery of comprehensive neuropsychological tests at baseline and after 5 years.
RESULTS: TLE patients showed a significant impairment in attention and psychomotor speed compared with controls after 5 years, while the other cognitive domains did not exhibit any important changes. This worsening was mainly related to the duration of epilepsy, the age at onset, a history of tonic-clonic seizures and a low educational level.
CONCLUSIONS: We believe that tapping the attention and psychomotor speed decline in TLE patients should be considered relevant for future research, in order to achieve a deeper understanding of the cognitive dimensions of this field.

Entities:  

Mesh:

Year:  2006        PMID: 16930944     DOI: 10.1016/j.eplepsyres.2006.04.004

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  12 in total

Review 1.  Magnetoencephalography for pediatric epilepsy: how we do it.

Authors:  E S Schwartz; D J Dlugos; P B Storm; J Dell; R Magee; T P Flynn; D M Zarnow; R A Zimmerman; T P L Roberts
Journal:  AJNR Am J Neuroradiol       Date:  2008-02-13       Impact factor: 3.825

2.  Brain structure and aging in chronic temporal lobe epilepsy.

Authors:  Kevin Dabbs; Tara Becker; Jana Jones; Paul Rutecki; Michael Seidenberg; Bruce Hermann
Journal:  Epilepsia       Date:  2012-04-03       Impact factor: 5.864

3.  Hippocampal atrophy and quantitative EEG markers in mild cognitive impairment in temporal lobe epilepsy versus extra-temporal lobe epilepsy.

Authors:  Mohammed Elsherif; Ahmed Esmael
Journal:  Neurol Sci       Date:  2021-08-18       Impact factor: 3.307

4.  Age-accelerated psychomotor slowing in temporal lobe epilepsy.

Authors:  Connie Sung; Jana E Jones; Daren C Jackson; Yui Chung Chan; Fong Chan; Michael Seidenberg; Bruce P Hermann
Journal:  Epilepsy Res       Date:  2012-09-16       Impact factor: 3.045

Review 5.  Curing epilepsy: progress and future directions.

Authors:  Margaret P Jacobs; Gabrielle G Leblanc; Amy Brooks-Kayal; Frances E Jensen; Dan H Lowenstein; Jeffrey L Noebels; Dennis D Spencer; John W Swann
Journal:  Epilepsy Behav       Date:  2009-03       Impact factor: 2.937

Review 6.  Impaired vigilance networks in temporal lobe epilepsy: Mechanisms and clinical implications.

Authors:  Dario J Englot; Victoria L Morgan; Catie Chang
Journal:  Epilepsia       Date:  2020-01-04       Impact factor: 5.864

Review 7.  Cognitive progression in epilepsy.

Authors:  Michael Seidenberg; Dalin T Pulsipher; Bruce Hermann
Journal:  Neuropsychol Rev       Date:  2007-11-08       Impact factor: 6.940

8.  NRSF and BDNF polymorphisms as biomarkers of cognitive dysfunction in adults with newly diagnosed epilepsy.

Authors:  Alix Warburton; Fabio Miyajima; Kanvel Shazadi; Joanne Crossley; Michael R Johnson; Anthony G Marson; Gus A Baker; John P Quinn; Graeme J Sills
Journal:  Epilepsy Behav       Date:  2015-12-17       Impact factor: 2.937

9.  Psychomotor slowing is associated with anomalies in baseline and prospective large scale neural networks in youth with epilepsy.

Authors:  Camille Garcia-Ramos; Kevin Dabbs; Elizabeth Meyerand; Vivek Prabhakaran; David Hsu; Jana Jones; Michael Seidenberg; Bruce Hermann
Journal:  Neuroimage Clin       Date:  2018-04-20       Impact factor: 4.881

10.  Factors for cognitive impairment in adult epileptic patients.

Authors:  Lei Wang; Shenggen Chen; Changyun Liu; Wanhui Lin; Huapin Huang
Journal:  Brain Behav       Date:  2019-12-21       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.